TVTXTravere Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+14% of shares).
Choppy, but holding above its 200-day average. Oversold (RSI 21). Price is +19% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How TVTX is trading
Travere Therapeutics, Inc. is +110% over the past year while the S&P 500 is +18%: 91 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +19%
vs 200-day average · a clear uptrend
- RSI (14)
- 21
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 23%
Below its 52-week high
Details›
- Last close2026-10-09
- $52.12
- 1 monthS&P 500 +2.7%
- −23%
- 1 yearS&P 500 +18%
- +110%
- 5 yearsS&P 500 +88%
- +121%
- vs 50-day average$61.80
- −16%
- 52-week high
- $67.51
- 52-week low
- $23.90
- Annualised volatility
- 66%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$447K
| Year | Return |
|---|---|
| 2026 (year to date) | +36% |
| 2025 | +119% |
| 2024 | +94% |
| 2023 | −57% |
| 2022 | −32% |
| 2021 | +14% |
| 2020 | +92% |
| 2019 | −37% |
| 2018 | +7.4% |
| 2017 | +11% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +0.72% |
| Feb | 10 | 6 of 10 | +2.3% |
| Mar | 10 | 3 of 10 | −6.7% |
| Apr | 10 | 5 of 10 | +2.9% |
| May | 10 | 4 of 10 | −5.2% |
| Jun | 10 | 6 of 10 | +7.9% |
| Jul | 11 | 6 of 11 | +1.9% |
| Aug | 11 | 6 of 11 | +6.7% |
| Sep | 11 | 5 of 11 | +5.2% |
| Oct | 11 | 5 of 11 | +2.4% |
| Nov | 10 | 5 of 10 | +2.1% |
| Dec | 10 | 6 of 10 | +5.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.